ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹604 Cr | ₹512 Cr | ₹475 Cr | ₹405 Cr | ₹398 Cr |
What is the latest Total Liabilities ratio of ALBERT DAVID ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹604 Cr |
Mar2023 | ₹512 Cr |
Mar2022 | ₹475 Cr |
Mar2021 | ₹405 Cr |
Mar2020 | ₹398 Cr |
How is Total Liabilities of ALBERT DAVID Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹604 Cr | 17.98 | |
Mar2023 | ₹512 Cr | 7.82 | |
Mar2022 | ₹475 Cr | 17.24 | |
Mar2021 | ₹405 Cr | 1.78 | |
Mar2020 | ₹398 Cr | - |
Compare Total Liabilities of peers of ALBERT DAVID
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALBERT DAVID | ₹493.0 Cr | 1.7% | 4.8% | -27.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics |
ALBERT DAVID Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALBERT DAVID | 1.7% |
4.8% |
-27.7% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses